SCHEMBL12470

SCHEMBL12470

c1cc2cc[nH]c2cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL706764 1.00 MAPT (0.50)
SCHEMBL29465576 1.00
SCHEMBL27728878 0.98
Hydrochloric Acid SCHEMBL5532283 0.98 MAPT (0.49)
Hydrochloric Acid SCHEMBL2978417 0.98 MAPT (0.49)
SCHEMBL7491548 0.98 MAPT (0.49)
Bromide SCHEMBL1242434 0.98 MAPT (0.49)
SCHEMBL17372872 0.92 MAPT (0.45)
Formic Acid SCHEMBL23291890 0.88 CCNC (0.44)
Sulfuric Acid SCHEMBL3830347 0.88 MAPT (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5461 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4482583-B1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2026-04-01 EP claimed
US-12528822-B2 Cycloalkane-1,3-diamine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2026-01-20 US claimed
EP-4678634-A1 ANDROGEN RECEPTOR MODULATORS AND USES THEREOF Haihe Biopharma Co., Ltd. (CN) 2026-01-14 EP claimed
US-20250388599-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2025-12-25 US claimed
US-20250387504-A1 ANTIBODY-DRUG CONJUGATES OF ANTINEOPLASTIC COMPOUNDS AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2025-12-25 US claimed
US-20250179066-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2025-06-05 US claimed
WO-2025111431-A1 ANTI-CD7 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF LES LABORATOIRES SERVIER (FR) 2025-05-30 WO claimed
WO-2025082069-A1 COMPOUND BINDING TO CRBN PROTEIN AND DEGRADATION AGENT OF PROTEIN 中国海洋大学 2025-04-24 WO claimed
CN-119841843-A Compound combined with CRBN protein and degradation agent of CRBN protein 中国海洋大学 2025-04-18 CN claimed
WO-2025076059-A1 ROCAGLATE DERIVATIVES AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-04-10 WO claimed
WO-2001005758-A2 INDOLES AND INDAZOLES FOR THE TREATMENT OF MIGRAINE NPS ALLELIX CORP. (CA) 2001-01-25 WO claimed
WO-2000075139-A2 BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2000-12-14 WO claimed
WO-2000037074-A1 MUTILIN 14-ESTER DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2000-06-29 WO claimed
US-5484793-A NERVOUS SYSTEM DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1996-01-16 US claimed
US-5468757-A FOR TREATING STROKE OR MYOCARDIAL INFARCTION IN HUMANS ELI LILLY AND COMPANY (US) 1995-11-21 US claimed
EP-0668279-A2 6-Azaindole thromboxane synthase inhibitors ELI LILLY AND COMPANY (US) 1995-08-23 EP claimed
EP-0586526-A1 AZA-6-INDOLE-DERIVED COMPOUNDS AS BENZODIAZEPINE RECEPTOR LIGANDS AND DRUGS CONTAINING SAME CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1994-03-16 EP claimed
WO-1992021680-A1 AZA-6-INDOLE-DERIVED COMPOUNDS AS BENZODIAZEPINE RECEPTOR LIGANDS AND DRUGS CONTAINING SAME CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1992-12-10 WO claimed
EP-0187631-B1 PROCESS FOR THE PREPARATION OF PYRROLOPYRIDINE DERIVATIVES, AND DERIVATIVES SO OBTAINED SANOFI (FR) 1990-09-05 EP claimed
EP-0186431-B1 ANTI-HYPERTENSIVE OCTAHYDRO-6-AZAINDOLE DIPEPTIDE DERIVATIVES Pfizer Limited (GB) 1988-02-03 EP claimed